News

MA based novel topical drug delivery company, today announced plans for a Phase 3 study of Sildenafil Cream, 3.6%, an investigational topical cream formulation of sildenafil being developed as an ...
Doctors prescribe sildenafil off-label to some female patients, either in the form of low doses of the pill or as a topical cream made by compounding pharmacies. Telehealth companies, like Alloy ...
“Impact of age, race, and medication use on efficacy endpoints in a randomized controlled trial of topical sildenafil cream for the treatment of female sexual arousal disorder.” Sexual ...
About SST-6006 SST-6006, developed with SST’s proprietary KNOSIS™ technology, is a patented topical cream product containing 5% sildenafil citrate by weight. Sildenafil is a specific PDE-5 ...
Sildenafil Cream is a proprietary topical formulation of sildenafil, a phosphodiesterase-5 (PDE-5) inhibitor, being developed as a first-in-category option for the treatment of FSAD. FSAD is the ...
Sildenafil Cream is an investigational, proprietary cream formulation of sildenafil designed for topical administration to the vulvar-vaginal tissue on demand to increase genital blood flow and ...
A 2024 study found that topical sildenafil cream improved outcomes for people with FSIAD. Anyone who would like to try Viagra should ask a medical professional, who may prescribe the drug off-label.
DARE BIOSCIENCE SAYS MET FUNDING REQUIREMENT FOR OBTAINING EXCLUSIVE WORLDWIDE LICENSE TO ADVANCE SST-6007 (5% TOPICAL SILDENAFIL CITRATE CREAM) * DARE BIOSCIENCE - PLANS TO PURSUE 505(B)(2 ...
proprietary cream formulation of sildenafil designed for topical administration to the vulvar-vaginal tissue on demand to increase genital blood flow and provide improvements in the female genital ...
Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD) ...